English | Español

Astellas Pharma Us, Inc.
Carol Ostrow | Dec 3, 2017

Astellas will present AML findings at American Society of Hematology conference
Carrie Bradon | Dec 1, 2017

Astellas study shows women with overactive bladder symptoms use unconventional methods
Carrie Bradon | Nov 25, 2017

Astellas Oncology names C3 Prize winners
Marian Johns | Nov 19, 2017

Astellas receives perfect score on Corporate Equality Index for fourth consecutive year
Marian Johns | Oct 22, 2017

FDA grants fast-track status to Astellas' acute myeloid leukemia drug
Marian Johns | Oct 19, 2017

Astellas Pharma, Seattle Genetics begin clinical trial for bladder cancer treatment
Robert Hadley | Jul 7, 2017

Astellas says gilteritinib may be long-sought treatment in certain acute myeloid leukemia cases
Robert Hadley | Jun 22, 2017

Phase 3 trial of Pfizer’s prostate cancer drug could yield results two years early

Trending
+ Community
Patient Daily | Apr 17, 2025

ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+ Pharmaceuticals
Patient Daily | Apr 17, 2025

UCSF neurosurgeon: 'The idea that 340B is about helping the poor is a fiction'
+ Pharmaceuticals
Patient Daily | Apr 17, 2025

AI tool decodes cerebellar signals to improve understanding of brain disorders
+ Pharmaceuticals
Patient Daily | Apr 23, 2025

Empower Pharmacy CEO on pharmaceutical industry pricing disparities: 'Is it fair to charge one person in another country 10 times more?'